JLBC
J.L. Bainbridge & Co’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-303,693
| Closed | -$21.9M | – | 73 |
|
|
2022
Q4 | $21.9M | Sell |
303,693
-551
| -0.2% | -$39.6K | 3.39% | 14 |
|
|
2022
Q3 | $21.6M | Sell |
304,244
-5,682
| -2% | -$404K | 3.31% | 12 |
|
|
2022
Q2 | $23.9M | Sell |
309,926
-274,594
| -47% | -$21.1M | 3.55% | 11 |
|
|
2022
Q1 | $42.7M | Sell |
584,520
-11,224
| -2% | -$820K | 4.86% | 6 |
|
|
2021
Q4 | $37.1M | Sell |
595,744
-19,443
| -3% | -$1.21M | 4.13% | 7 |
|
|
2021
Q3 | $36.4M | Sell |
615,187
-13,879
| -2% | -$821K | 4.34% | 6 |
|
|
2021
Q2 | $42M | Buy |
629,066
+4,779
| +0.8% | +$319K | 5.02% | 4 |
|
|
2021
Q1 | $39.4M | Buy |
624,287
+4,127
| +0.7% | +$261K | 5.2% | 5 |
|
|
2020
Q4 | $38.5M | Sell |
620,160
-11,775
| -2% | -$730K | 5.42% | 4 |
|
|
2020
Q3 | $38.1M | Sell |
631,935
-11,450
| -2% | -$690K | 6.04% | 4 |
|
|
2020
Q2 | $37.8M | Buy |
643,385
+36,596
| +6% | +$2.15M | 6.88% | 4 |
|
|
2020
Q1 | $33.8M | Buy |
606,789
+4,186
| +0.7% | +$233K | 6.43% | 4 |
|
|
2019
Q4 | $38.7M | Buy |
+602,603
| New | +$38.7M | 5.38% | 8 |
|